Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients

PURPOSE: The on-body injector (OBI) automatically delivers pegfilgrastim the day after chemotherapy (CTx), thus eliminating the need of return visits to the medical office for guideline-compliant pegfilgrastim administration. The CONVENIENCE study aimed to evaluate patient, nurse, and physician pref...

Descripción completa

Detalles Bibliográficos
Autores principales: Metz, Michael, Semsek, Dieter, Rogmans, Gunther, Hutzschenreuter, Ulrich, Fietz, Thomas, Harde, Johanna, Zacharias, Stefan, Hielscher, Carsten, Lorenz, Andreas, Zahn, Mark-Oliver, Guth, Dagmar, Liebers, Steffen, Berghorn, Michael, Grebhardt, Sina, Matillon, Christiane D., Egerer, Gerlinde, Potthoff, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464571/
https://www.ncbi.nlm.nih.gov/pubmed/33956213
http://dx.doi.org/10.1007/s00520-021-06230-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464571/
https://www.ncbi.nlm.nih.gov/pubmed/33956213
http://dx.doi.org/10.1007/s00520-021-06230-9

Ejemplares similares